Ladders to Cures Bets on 'Nodal Biology' to Make Rare Disease Drugs Profitable
Health

Ladders to Cures Bets on 'Nodal Biology' to Make Rare Disease Drugs Profitable

A Harvard-led accelerator is hunting for shared biological mechanisms across rare diseases, aiming to build single drugs...

Noa Feldman 👁 22 💬 0
Catherine Larue: From Heart Attack Biomarker to Biotech Consultancy
Health

Catherine Larue: From Heart Attack Biomarker to Biotech Consultancy

Catherine Larue's career spans pharmaceutical research, biobank leadership, and founding CoDx, a consultancy that helps ...

Noa Feldman 👁 37 💬 0
Scientists Uncover Neuron 'Gatekeeper' That Could Lead to New Alzheimer's Therapies
Health

Scientists Uncover Neuron 'Gatekeeper' That Could Lead to New Alzheimer's Therapies

Discovery of a cellular skeleton's gatekeeping role links endocytosis to Alzheimer's plaque formation, opening a fresh a...

Noa Feldman 👁 39 💬 0
Alzheimer's Research Spent Billions Chasing Dead-End Amyloid Hypothesis, Critics Say
Health

Alzheimer's Research Spent Billions Chasing Dead-End Amyloid Hypothesis, Critics Say

Despite decades of failure and an estimated tens of billions of dollars in wasted spending, the dominant Alzheimer's res...

Noa Feldman 👁 44 💬 0